Klinik für Hals-, Nasen-, Ohren- Krankheiten, Hals-und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland.
Department of Otolaryngology, Harvard Medical School, Boston, MA, USA.
Eur Arch Otorhinolaryngol. 2019 Oct;276(10):2827-2833. doi: 10.1007/s00405-019-05569-4. Epub 2019 Jul 19.
The effects of nasal obstruction in patients with chronic rhinosinusitis (CRS) are associated with depressed mood. We sought to validate this finding by determining whether improvement in nasal obstruction would translate to improvement in depressed mood.
This was a prospective observational study of 150 patients undergoing medical management for CRS. Data were collected at two timepoints: enrollment and a subsequent follow-up visit 3-12 months later. Impact of nasal obstruction was measured using the Nasal Obstruction Symptom Evaluation (NOSE) instrument and depressed mood was measured using the 2-item Patient Health Questionnaire (PHQ-2). Sinonasal symptoms associated with CRS were also measured using the 22-item Sinonasal Outcome Test (SNOT-22). Clinical and demographic characteristics were collected. The relationship between changes in PHQ-2 and NOSE scores was determined with correlation and linear regression.
Change in PHQ-2 score was significantly correlated with change in NOSE score (ρ = 0.30, p < 0.001). After controlling for covariates, change in PHQ-2 score was associated with change in NOSE score (adjusted linear regression coefficient [β] = 0.014, 95% CI 0.006-0.022, p = 0.001). We confirmed these relationships, finding that change in PHQ-2 was associated (adjusted β = 0.037, 95% CI 0.013-0.061, p = 0.003) with change in the nasal subdomain score of the SNOT-22. Improvement in NOSE score by greater than 22 points was predictive of improvement in PHQ-2 score with sensitivity 54.5% and 83.8% specificity (p < 0.001).
These results provide evidence that improvements in nasal manifestations/symptoms of CRS translate to significant improvements in mood.
慢性鼻-鼻窦炎(CRS)患者的鼻塞症状与情绪低落有关。我们试图通过确定鼻塞症状的改善是否能转化为情绪低落的改善来验证这一发现。
这是一项对 150 名接受 CRS 药物治疗的患者进行的前瞻性观察研究。数据在两个时间点收集:入组时和随后的 3-12 个月随访时。使用鼻腔阻塞症状评估(NOSE)量表评估鼻塞症状的影响,使用 2 项患者健康问卷(PHQ-2)评估抑郁情绪。使用 22 项鼻-鼻窦结局测试(SNOT-22)评估与 CRS 相关的鼻-鼻窦症状。收集临床和人口统计学特征。通过相关性和线性回归确定 PHQ-2 和 NOSE 评分变化之间的关系。
PHQ-2 评分的变化与 NOSE 评分的变化显著相关(ρ=0.30,p<0.001)。在控制了协变量后,PHQ-2 评分的变化与 NOSE 评分的变化相关(调整后的线性回归系数[β]为 0.014,95%CI 0.006-0.022,p=0.001)。我们确认了这些关系,发现 PHQ-2 的变化与 SNOT-22 的鼻腔亚域评分的变化相关(调整后的β为 0.037,95%CI 0.013-0.061,p=0.003)。NOSE 评分改善超过 22 分可预测 PHQ-2 评分的改善,敏感性为 54.5%,特异性为 83.8%(p<0.001)。
这些结果提供了证据表明,CRS 的鼻腔表现/症状的改善转化为情绪的显著改善。